Published in Scand J Infect Dis Suppl on January 01, 1978
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother (2004) 1.64
Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun (2006) 1.04
Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother (1989) 0.88
Aztreonam penetration into synovial fluid and bone. Antimicrob Agents Chemother (1986) 0.77
[Bone concentrations of imipenem after a dose of imipenem/cilastatin]. Infection (1986) 0.75
Concentration of cefuroxime in the bones of albino white rats: a comparative study of femur, humerus, and mandible. Arch Orthop Trauma Surg (1986) 0.75
Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother (1982) 3.84
Extrachromosomal control of methicillin resistance and toxin production in Staphylococcus aureus. J Bacteriol (1969) 3.34
Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis Suppl (1979) 2.66
Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase. Antimicrob Agents Chemother (1999) 2.27
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.15
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Transduction of penicillinase production and methicillin resistance-enterotoxin B production in strains of Staphylococcus aureus. J Gen Microbiol (1973) 1.85
Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS (2007) 1.82
Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis (1988) 1.62
Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis (1974) 1.57
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol (1977) 1.55
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis (1975) 1.54
In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol (1974) 1.47
Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother (1980) 1.45
Antibiotic susceptibility of Clostridium species isolated from human infections. Scand J Infect Dis (1975) 1.25
Some properties of coagulase-negative deoxyribonuclease-producing strains of staphylococci from human infections. Med Microbiol Immunol (1976) 1.16
Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. J Antimicrob Chemother (1992) 1.15
Determination of methicillin resistance of Staphylococcus aureus. Heterogeneity and its influence on the disc diffusion method. Scand J Infect Dis (1969) 1.15
Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate. J Antimicrob Chemother (1994) 1.10
Genetic aspects of methicillin resistance and toxin production in a strain of Staphylococcus aureus. Ann N Y Acad Sci (1971) 0.99
Antibacterial activity of clindamycin and lincomycin in human bone. J Antimicrob Chemother (1977) 0.97
Antibacterial activity of cefuroxime in human bone. Scand J Infect Dis (1980) 0.97
[Resistance determination of bacteria: new classification in sensitive groups--S, I and R]. Lakartidningen (1978) 0.97
Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica. Scand J Infect Dis (1977) 0.95
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment. J Antimicrob Chemother (1996) 0.95
Effect of trimethoprim or trimethoprim/sulphamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens. Scand J Infect Dis (1981) 0.94
Susceptibility testing to trimethoprim alone and combined with sulphonamides. Chemotherapy (1980) 0.93
Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime. J Antimicrob Chemother (1991) 0.93
beta-lactamases in bacteroides. Scand J Infect Dis Suppl (1978) 0.92
Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole. Chemotherapy (1971) 0.92
Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates. J Antimicrob Chemother (1993) 0.90
Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area. Antimicrob Agents Chemother (1999) 0.90
Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp. APMIS (1990) 0.89
Comparison of direct and standardized antibiotic susceptibility testing in bacteriuria. Chemotherapy (1981) 0.88
Bacteriuria diagnosis and antibiotic susceptibility testing in a group practice by dipslide techniques. Chemotherapy (1979) 0.84
Evaluation of a disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa. APMIS (1989) 0.82
The role of biotransformation in the genotoxicity of allylic compounds. Arch Toxicol (1987) 0.82
Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 0.82
beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection. Scand J Infect Dis Suppl (1978) 0.82
Influence of medium composition on bacterial susceptibility testing to gentamicin and netilmicin. Scand J Infect Dis Suppl (1980) 0.81
Characterization of beta-lactam-resistant Klebsiella oxytoca isolated in a neonatal intensive care unit. APMIS (1991) 0.81
Levels of trimethoprim and sulfamethoxazole in human oviduct mucosa and plasma. Acta Obstet Gynecol Scand (1982) 0.79
Metabolism of 2,3-dichloro-1-propene in the rat. Consideration of bioactivation mechanisms. Drug Metab Dispos (1988) 0.79
Interpretation of the agar diffusion method for bacterial susceptibility testing. J Antimicrob Chemother (1981) 0.79
Extracellular proteins in five clostridial species from human infections. Med Microbiol Immunol (1975) 0.78
A genetic study of inducible erythromycin resistance in Staphylococcus aureus. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 0.78
Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. A clinical study. Scand J Infect Dis Suppl (1976) 0.78
Studies on beta-lactamase in Bacteroides fragilis. Infection (1980) 0.77
Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. Int J Oral Surg (1978) 0.77
Antibacterial susceptibility testing by the dip-slide technique: a methodological evaluation. Chemotherapy (1976) 0.77
In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. Scand J Infect Dis (1986) 0.77
Compatibility tests between genetic linkage groups in a strain of Staphylococcus aureus. J Gen Microbiol (1973) 0.77
Levels of trimethoprim and sulphamethoxazole in human seminal plasma. Andrologia (1977) 0.77
Comparative study of netilmicin/tinidazole versus netilmicin/clindamycin in the treatment of severe abdominal infections. Scand J Infect Dis (1984) 0.77
Gentamicin resistance in gram-negative bacilli: occurrence of modifying enzymes and their influence on susceptibility testing. Scand J Infect Dis (1980) 0.76
The detection of doxycycline activity in human bone. Scand J Infect Dis Suppl (1976) 0.76
Synergy and cumulated killing effect of the penems FCE 22101 and FCE 25199 in combination with gentamicin against bacteria isolated from septicaemia. APMIS (1991) 0.75
Use of electrophoresis in the identification and quantitation of antibiotics administered in combinations. Scand J Infect Dis (1977) 0.75
Transferable trimethoprim resistance in urinary tract pathogens isolated in Finland and Sweden. Scand J Infect Dis (1983) 0.75
Cefuroxime in soft tissue infections and septicaemia. Scand J Infect Dis (1980) 0.75
Secretion of metronidazole into the human semen. Int J Androl (1980) 0.75
Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporins. J Antimicrob Chemother (1981) 0.75
In vitro susceptibility to tetracycline and doxycycline in clinical isolates of Haemophilus influenzae. Scand J Infect Dis Suppl (1988) 0.75
Regression line analysis for five antibiotics with strains of Clostridium species. Scand J Infect Dis (1975) 0.75
Concentrations of oxytetracycline, tetracycline and doxycycline in mandibular osteitis. Scand J Infect Dis Suppl (1976) 0.75
Trimethoprim and sulphamethoxazole: determination of bacterial sensitivity and drug concentration in human serum. Scand J Infect Dis Suppl (1976) 0.75
Antibiotic susceptibility in oral bacteria. Swed Dent J (1980) 0.75
Susceptibility testing of Klebsiella spp.--an international collaborative study in quality assessment. J Antimicrob Chemother (1998) 0.75
Studies on the clinical efficacy, serum levels and side effects of clindamycin phosphate administered intravenously. Scand J Infect Dis (1977) 0.75
Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial. J Chemother (1999) 0.75
Scandinavian quality surveys of gentamicin assays 1978-1983. Scand J Infect Dis (1985) 0.75
The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo. J Chemother (1989) 0.75
Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101. J Antimicrob Chemother (1990) 0.75
Genotoxicity of allyl compounds--a quick screening strategy based on structure-activity relationships and a battery of prescreening tests. Food Chem Toxicol (1987) 0.75
Evaluation of microdilution trays (sensititre) for antimicrobial susceptibility testing of Bacteroides fragilis. Med Microbiol Immunol (1978) 0.75
In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam. J Antimicrob Chemother (1982) 0.75
Microbiological assay of mixtures of ampicillin and cloxacillin in plasma after separation by high voltage electrophoresis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 0.75
Monitoring antimicrobial therapy in bacterial endocarditis. Scand J Infect Dis Suppl (1983) 0.75
European Cooperative Study of the prevalence of antibiotic resistance in Haemophilus. J Chemother (1989) 0.75
In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases. J Antimicrob Chemother (1985) 0.75
Occurrence and transfer of ampicillin resistance associated with ampicillin-resistant Haemophilus influenzae isolated from a case at a day-care centre. Scand J Infect Dis (1977) 0.75
[High resistance to antibiotics in urinary tract infections. Simple questions can eliminate the need for resistance determination in patients with urinary tract infections]. Lakartidningen (1985) 0.75
Susceptibility of bacteria isolated from oral infections to nine antibiotics in vitro. Swed Dent J (1978) 0.75
Application of electrophoresis for separation of trimethoprim and sulphamethoxazole in combined therapy. Acta Pathol Microbiol Scand B (1975) 0.75
Assay of gentamicin concentrations in serum specimens by microbiological and radioenzymatic methods. Scand J Infect Dis (1977) 0.75
[Plasmides from Staphylococcus aureus]. Nord Med (1971) 0.75